| Proizvajalec | Hilma Biocare |
| Aktivni razpolovni čas (ure) | 48 do 72 ur |
| Vrsta zdravila | Peptidni hormon |
| Kategorija zdravila | Injekcija/Prah |
| Odmerek | 2 mg (2000 mcg) |
| Uporaba za moške | 200-1000 mcg |
| Embalaža izdelka | 1 viala |
| Učinkovina | Pegilirani mehanogrowth faktor (MGF) |
| Zadrževanje vode | Ne |
| Aromatizacija | Ne |
-
-12%
-
Group: Injection/powder Active Half-life (min): 120 to 160 Subgroup: Peptide hormone Dosage: 10 mg Application (Men): 0,1-1 mg, depending on the treatment plan Product pack: 1 vial Content (active): PT-141 (Bremelanotide) Retains water: No Aromatization: No -
Active Half-life : up to 7 days Group: Peptide hormone Subgroup: Injection / lyophilized powder Dosage: 2 mg/ml Application (Men): 0,25-1 mg a week (consult your physician) Product pack: 1 vial Content (active): Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) Retains water: No Aromatization: No -
Active Half-life : approximately 1 week (165–184 hours) Group: Peptide hormone Subgroup: Injection / lyophilized powder Dosage: 5 mg Application (Men): 2,5 to 15 mg Product pack: 3 ml (Injection Pen) Content (active): Semaglutide Retains water: not recognized Aromatization: No -
Group: Injection/powder Active Half-life (min): 7 to 30 Subgroup: Peptide hormone Dosage: 10 mg Application (Men): 200-1000 mcg Product pack: 1 vial Content (active): SS-31 Retains water: No Aromatization: No -
-10%
Proizvajalec Hilma Biocare Aktivni razpolovni čas (ure) 48 do 72 ur Vrsta zdravila Peptidni hormon Kategorija zdravila Injekcija/Prah Odmerek 5 mg (5000 mcg) Uporaba za moške 2 do 3 mg na 3 do 4 dni Embalaža izdelka 1 viala Učinkovina Thymosin Beta 4 Zadrževanje vode Ne Aromatizacija Ne